XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
EQUITY TRANSACTIONS (Tables)
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of warrant activity
                               
    Fiscal Year Ended March 31,  
    2024     2023  
    Warrants     Weighted
Average
Exercise Price
    Warrants     Weighted
Average
Exercise Price
 
Outstanding, beginning of year     32,676     $ 20.09       57,678     $ 112.11  
Granted         $ N/A           $ N/A  
Exercised         $ N/A           $ N/A  
Cancelled/Forfeited         $ N/A       (25,002 )   $ 232.38  
Outstanding, end of year     32,676     $ 20.09       32,676     $ 20.09  
Exercisable, end of year     32,676     $ 20.09       32,676     $ 20.09  
Weighted average estimated fair value of warrants granted           $ N/A             $ N/A  
Schedule of warrant activity exercisable and outstanding
                                       
      Warrants Outstanding       Warrants Exercisable  
Range of
Exercise Prices
    Number
Outstanding
      Weighted
Average
Remaining
Life (Years)
      Weighted
Average
Exercise Price
      Number
Outstanding
      Weighted
Average
Exercise Price
 
$18.75 or Below     20,217       .71     $ 15.66       20,217     $ 15.66  
$25.00 - $27.50     12,459       .81     $ 27.28       12,459     $ 27.28  
      32,676                       32,676          

 

The detail of the warrants outstanding and exercisable as of March 31, 2023 is as follows:

                                         
      Warrants Outstanding       Warrants Exercisable  
Range of
Exercise Prices
    Number
Outstanding
      Weighted
Average
Remaining
Life (Years)
      Weighted
Average
Exercise Price
      Number
Outstanding
      Weighted
Average
Exercise Price
 
$18.75 or Below     20,217       1.71     $ 15.66       20,217     $ 15.66  
$25.00 - $27.50     12,459       1.81     $ 27.28       12,459     $ 27.28  
      32,676                       32,676          
Schedule of options outstanding that have vested and are expected to vest
                       
    Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term in
Years
 
Vested     57,813     $ 19.41       6.96  
Expected to vest     28,653     $ 15.01       7.78  
Total     86,466                  
Schedule of stock option activity
                
   Fiscal Year Ended March 31, 
   2024   2023 
   Options   Weighted
Average
Exercise Price
   Options   Weighted
Average
Exercise Price
 
Outstanding, beginning of year   171,825   $22.4    166,595   $23.1 
Granted      $    12,222   $9.50 
Cancelled/Forfeited   (85,359)  $26.89    (6,992)  $17.70 
Outstanding, end of year   86,466   $17.95    171,825   $22.4 
Exercisable, end of year   57,813   $19.41    75,554   $24.5 
Weighted average estimated fair value of options granted       $N/A        $N/A 
Schedule of nonvested shares
          
   Shares   Weighted Average Grant Date Fair Value 
Nonvested stock options at April 1, 2023   96,273   $19.99 
Vested   (21,934)  $1.59 
Forfeited   (45,686)  $2.55 
Nonvested stock options at March 31, 2024   28,653     
Schedule of detail of options outstanding and exercisable by exercise price
                                           
          Options Outstanding       Options Exercisable  
  Exercise Prices       Number
Outstanding
      Weighted
Average
Remaining
Life (Years)
      Weighted
Average
Exercise
Price
      Number
Outstanding
      Weighted
Average
Exercise
Price
 
  $6.90 - $16.80       62,204       7.48 years     $ 13.24       38,589     $ 13.48  
  $25.20       24,178       6.76 years     $ 25.20       19,140     $ 25.20  
  $1,425.00       84       .18 years     $ 1,425.00       84     $ 1,425.00  
          86,466                       57,813          
Schedule of RSUs
Schedule of RSUs    
   Shares 
Nonvested RSUs at April 1, 2023    
Granted   54,428 
Vested   (34,378)
      
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units   (15,165)
Nonvested RSUs at March 31, 2024   4,885 
Schedule of stock-based compensation
        
   Fiscal Year Ended 
   March 31, 2024   March 31, 2023 
Vesting of restricted stock units  $206,250   $175,000 
Vesting of stock options   1,013,120    876,898 
Total Stock-Based Compensation  $1,219,370   $1,051,898